CCX559 is a potent orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.

被引：0

作者：

Li, Chris ^{[1
]}

Vilalta, Marta ^{[1
]}

Ertl, Linda S. ^{[1
]}

Wang, Yu ^{[1
]}

Zeng, Yibin ^{[1
]}

Fan, Pingchen ^{[1
]}

Lange, Christopher ^{[1
]}

McMurtrie, Darren ^{[1
]}

Yang, Ju ^{[1
]}

Lui, Rebecca ^{[1
]}

Scamp, Ryan ^{[1
]}

Chhina, Vicky ^{[1
]}

Kumamoto, Alice ^{[1
]}

Ong, Ryan ^{[1
]}

Dang, Ton ^{[1
]}

Easterday, Ashton ^{[1
]}

Zhao, Niky ^{[1
]}

Liu, Shirley ^{[1
]}

Singh, Rajinder ^{[1
]}

Charo, Israel ^{[1
]}

Sullivan, Kathleen ^{[1
]}

Schall, Thomas J. ^{[1
]}

Zhang, Penglie ^{[1
]}

机构：

[1] ChemoCentryx, Mountain View, CA USA

来源：

CANCER RESEARCH | 2021年 / 81卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1274

引用

页数：1

共 50 条

[41] Clinical BET Inhibitor RG6146 Induces Intrinsic Apoptosis and Down-Regulates PD-L1 Expression and Induces Potent Anti-Tumor Activity in Models of Hematological Malignancy
Hogg, Simon J.
Wellinger, Lisa
Rueflibrasse, Astrid
Johnstone, Ricky Wayne
BLOOD, 2017, 130
[42] Anti-tumor Effect of PD-L1 Inhibitor Durvalumab Administered Before Surgery in Patients With HPV plus vs HPV-HNSCC
Porosnicu, M.
Waltonen, J. D.
Triozzi, P.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 100 (05): : 1316 - 1316
[43] TY-0584: A potent, orally available small molecule YAP/TEAD inhibitor, exhibits anti-tumor effects in vitro and in vivo
Liang, Apeng
Dong, Shengli
Liu, Guangbin
Guo, Zhengfei
Li, Meihua
Han, Shuaibo
Cao, Yundi
Tu, Yian
Zhou, Chao
Yu, Yu
Xiao, Linglin
Huang, Wei
Yang, Xinlong
Fang, Lian
Li, Haoyun
Niu, Chengshan
Jiang, Mingyu
Xing, Feng
Chen, Shaoqing
Li, Jun
Wu, Yusheng
CANCER RESEARCH, 2023, 83 (07)
[44] Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy
Liu, Chenglong
Zhou, Feilong
Yan, Ziqin
Shen, Lian
Zhang, Xichen
He, Fenglian
Wang, Heng
Lu, Xiaojie
Yu, Ker
Zhao, Yujun
Zhu, Di
BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (13) : 2651 - 2670
[45] Sharks give a handle to potent anti-tumor multiparatopic antibodies inducing membrane depletion of PD-L1
Wozniak-Knopp, Gordana
Natale, Veronica
CELL CHEMICAL BIOLOGY, 2024, 31 (05) : 833 - 834
[46] Co-immunizing with PD-L1 induces CD8+ DCs-mediated anti-tumor immunity in multiple myeloma
Guo, Shuli
Xiao, Pengli
Li, Bo
Wang, Wanli
Wang, Songyun
Lv, Tao
Xu, Xiaoyan
Chen, Cong
Huang, Lei
Li, Zhi
Tang, Li
Peng, Liang
Wang, Huirui
INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 84
[47] Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells
Zhou, Xinyi
Fu, Dongliang
Yang, Hang
Le, Chenqin
Lu, Yier
Wei, Jingsun
Tang, Yang
Zhang, Jiawei
Yuan, Ying
Ding, Kefeng
Xiao, Qian
CANCER LETTERS, 2023, 577
[48] NOVEL SMALL MOLECULE HPK1 INHIBITOR PCC-1 INDUCES STRONG ANTI-TUMOR ACTIVITY
Das, Sanjib
Mandadi, Sravan
Saini, Jagmohan
Chaudhari, Sachin
Deshpande, Ameya
Chinnapattu, Murugan
Bajpai, Malini
Pangre, Priyanka
Potdar, Varada
Marathe, Megha
Sawant, Pooja
Akarte, Atul
Misra, Chandrasekhar
Das, Subhadip
Singh, Anuj
Das, Avratanu
Lambade, Pandurang
Tirumalasetty, Chaitanya
Patole, Raju
Biswas, Nilanjana
Karande, Vikas
Shah, Heta
Behera, Dayanidhi
Gowda, Nagaraj
Iyer, Pravin
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A889 - A889
[49] Enhanced Anti-Tumor Response Elicited by a Novel Oncolytic Pseudorabies Virus Engineered with a PD-L1 Inhibitor
Xiang, Guangtao
Wang, Mengdong
Wang, Pu
Li, Rifei
Gao, Chao
Li, Yue
Liang, Xinxin
Liu, Yun
Xu, Aotian
Tang, Jun
VIRUSES-BASEL, 2024, 16 (08):
[50] An Fc-competent bispecific antibody targeting PD-L1 and TIGIT induces strong immune responses and potent anti-tumor efficacy.
Dai, Shuang
Huang, Weifeng
Yuan, Zhijun
Peng, Shaogang
Si, Jiayi
Wang, Chao
Yan, Yao
Miao, Xiaoniu
Xu, Yingda
Sun, Joanne
Liu, Xiaolin
Tsun, Andy
Zhai, Tianhang
CANCER RESEARCH, 2022, 82 (12)

← 1 2 3 4 5 →